I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Encouraging Clinical Evolution of a Pediatric Patient With ..:
Yoshiko Hashii
;
Yoshihiro Oka
;
Naoki Kagawa
...
https://www.frontiersin.org/article/10.3389/fonc.2020.01188/full. , 2020
Link:
https://doi.org/10.3389/fonc.2020.01188
RT Journal T1 <Title>Encouraging Clinical Evolution of a Pediatric Patient With Relapsed Diffuse Midline Glioma Who Underwent WT1-Targeting Immunotherapy: A Case Report and Literature Review</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:1d662f20d7d34a838619aa5f8de91774&Exemplar=1&LAN=DE A1 Yoshiko Hashii A1 Yoshihiro Oka A1 Naoki Kagawa A1 Naoya Hashimoto A1 Hiroyuki Saitou A1 Syogo Fukuya A1 Mizuki Kanegae A1 Sayaka Ikejima A1 Yusuke Oji A1 Keiichi Ozono A1 Akihiro Tsuboi A1 Haruo Sugiyama PB Frontiers Media S.A. YR 2020 K1 WT1 peptide vaccine K1 immunotherapy K1 diffuse midline glioma K1 relapse K1 WT1-specific cytotoxic T cells K1 tetramer assay K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.frontiersin.org/article/10.3389/fonc.2020.01188/full LK http://dx.doi.org/https://doi.org/10.3389/fonc.2020.01188 DO https://doi.org/10.3389/fonc.2020.01188 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
